Monogenic causes of familial short stature

Front Endocrinol (Lausanne). 2024 Dec 19:15:1506323. doi: 10.3389/fendo.2024.1506323. eCollection 2024.

Abstract

Genetic factors play a crucial role in determining human height. Short stature commonly affects multiple family members and therefore, familial short stature (FSS) represents a significant proportion of growth disorders. Traditionally, FSS was considered a benign polygenic condition representing a subcategory of idiopathic short stature (ISS). However, advancements in genetic research have revealed that FSS can also be monogenic, inherited in an autosomal dominant manner and can result from different mechanisms including primary growth plate disorders, growth hormone deficiency/insensitivity or by the disruption of fundamental intracellular pathways. These discoveries have highlighted a broader phenotypic spectrum for monogenic forms of short stature, which may exhibit mild manifestations indistinguishable from ISS. Given the overlapping features and the difficulty in differentiating polygenic from monogenic FSS without genetic testing, some researchers redefine FSS as a descriptive term that encompasses any familial occurrence of short stature, regardless of the underlying cause. This shift emphasizes the complexity of diagnosing and managing short stature within families, reflecting the diverse genetic landscape that influences human growth.

Keywords: autosomal dominant short stature; familial short stature; genetics; growth plate; short stature.

Publication types

  • Review

MeSH terms

  • Body Height* / genetics
  • Dwarfism / genetics
  • Growth Disorders* / genetics
  • Humans
  • Phenotype

Grants and funding

The author(s) declare financial support was received for the research, authorship, and/or publication of this article. Supported by the Ministry of Health of the Czech Republic grant No. NU22J-07-00014 and conceptual development of research organization, Motol University Hospital, Prague, Czech Republic, 00064203.